Description
This study has been reviewed and approved by the Medical University of South Carolina (MUSC) Institutional Review Board.
This study is looking at a commonly used smoking cessation treatment Varenicline (Chantix®) combined with other interventions to potentially help people quit smoking cigarettes.
You will be compensated up to $1,050 for participating in this study.
Learn More:
Who can join?
Adults aged 18 to 40 years old who are interested in quitting smoking tobacco cigarettes.
Must be a tobacco user.
Discussion
By posting you agree to the Terms and Privacy Policy.